Digital illustration showing a cheerful scientist beside a beaker, a bullish stock chart, and a small cartoon bull — symbolizing Revvity’s blend of biotech innovation, strong institutional backing, and renewed investor optimism.

Some Funds Are Adding and Analysts Are Rather Bullish: Should You Buy Shares of Revvity (RVTY)?

Revvity (RVTY) may not make flashy headlines, but it’s quietly building a powerful comeback story. With top institutions buying, analysts turning bullish, and profits stabilizing, this former PerkinElmer spinout is morphing into a biotech value gem. Here’s why investors — and scientists — are both smiling (in lab coats).

Read entire article

Cartoon-style digital illustration of a sneaker-shaped stock chart bouncing on a trampoline labeled

Nike: Invest for Value in the Nick of Time?

Nike’s been knocked down, but insiders and institutions aren’t ready to quit. With strong cash flow, consistent dividends, and that iconic swoosh, is it time to just do it—or jog the other way?

Read entire article